The InFLAMES Flagship (Innovation Ecosystem based on the Immune System) is a joint effort of University of Turku and Åbo Akademi University aiming at being an internationally recognized, top-level, immunological research and development cluster which will be globally attractive both for the researchers and business partners.
The yearly organized doctoral module of the InFLAMES Flagship (Innovation Ecosystem based on the Immune System) is aimed to prepare the doctoral candidates for the various careers in immunology and immunology-related areas in both academic and business sectors. On this website you can find information regarding the application process for, as well as the contents and completion of the doctoral module.
Please note that as many of the practical considerations regarding the module are still under construction, these sites are expected to be frequently updated.
Researchers at the University of Turku, Finland, showed that the antibody treatment reactivates the immune defense in patients with advanced-stage cancer. The treatment alters the function of the body’s phagocytes and facilitates extensive activation of the immune system.
Although vaccination programmes against pertussis are very effective in Europe, new Finnish study shows that the disease is still very common among middle-aged adults in various European countries. At the same time, the results show that the disease is underdiagnosed as the annually reported figures are considerably lower than those discovered in the study.
The joint immunology flagship effort of the University of Turku and Åbo Akademi University is recruiting over 20 top experts. With the recruitments, the InFLAMES Flagship strengthens its role as the centre for top-level immunology research and development.
This year, the Elias Tillandz prize for the best scientific paper published in 2019 in BioCity Turku has been awarded to Academician Sirpa Jalkanen and her research group.
Cancer IO is a new cancer immunotherapy focused top-level collaborative research and innovation project that starts as a part of the Business Finland’s Personalized Health Program. With a total funding of 10 million euros, Cancer IO is a significant IO focused Nordic research and innovation program.